The claim
Russia’s EnteroMix cancer vaccine is turning heads—early trials show ‘100% efficacy'
Original review summary
The review says the 100% efficacy claim is not supported by validated evidence: it reports that the trial involved 48 patients and that results had not been published in a peer-reviewed journal. It describes EnteroMix as experimental, with effectiveness and safety still unproven.[S1]
Additional context
The review says Russian officials pledged free access for domestic cancer patients if the vaccine is approved, but found no evidence of free distribution worldwide. [S1]
Research date:
Sources and attribution
- [S1] Factcrescendo Sri Lanka original review
Original review · Retrieved October 16, 2026